PortfoliosLab logoPortfoliosLab logo
FTXH vs. XLVI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

FTXH vs. XLVI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First Trust Nasdaq Pharmaceuticals ETF (FTXH) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FTXH achieves a 10.44% return, which is significantly higher than XLVI's 2.50% return.


FTXH

1D
1.37%
1M
4.15%
YTD
10.44%
6M
9.18%
1Y
44.59%
3Y*
12.98%
5Y*
8.45%
10Y*

XLVI

1D
1.53%
1M
2.15%
YTD
2.50%
6M
2.57%
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

FTXH vs. XLVI - Yearly Performance Comparison


Correlation

The correlation between FTXH and XLVI is 0.83, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.


Correlation
Correlation (All Time)
Calculated using the full available price history since Jul 30, 2025

0.83

FTXH vs. XLVI - Sectors Allocation Comparison


Sectors
FTXH
XLVI

Healthcare

100.0%
100.0%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

100.2%

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

FTXH
100.0%
XLVI
100.0%

Basic Materials

FTXH

-

XLVI

-

Communication Services

FTXH

-

XLVI

-

Consumer Cyclical

FTXH

-

XLVI

-

Consumer Defensive

FTXH

-

XLVI

-

Energy

FTXH

-

XLVI

-

Financial Services

FTXH

-

XLVI
100.2%

Industrials

FTXH

-

XLVI

-

Real Estate

FTXH

-

XLVI

-

Technology

FTXH

-

XLVI

-

Utilities

FTXH

-

XLVI

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FTXH vs. XLVI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FTXH
FTXH Risk / Return Rank: 8787
Overall Rank
FTXH Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
FTXH Sortino Ratio Rank: 8989
Sortino Ratio Rank
FTXH Omega Ratio Rank: 8080
Omega Ratio Rank
FTXH Calmar Ratio Rank: 9393
Calmar Ratio Rank
FTXH Martin Ratio Rank: 8787
Martin Ratio Rank

XLVI

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FTXH vs. XLVI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FTXHXLVIDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.44

Calmar ratioReturn relative to maximum drawdown

6.00

Martin ratioReturn relative to average drawdown

17.65

FTXH vs. XLVI - Sharpe Ratio Comparison


Loading charts...

Drawdowns

FTXH vs. XLVI - Drawdown Comparison

The maximum FTXH drawdown since its inception was -32.11%, which is greater than XLVI's maximum drawdown of -8.14%. Use the drawdown chart below to compare losses from any high point for FTXH and XLVI.


Loading charts...

Drawdown Indicators


FTXHXLVIDifference

Max Drawdown

Largest peak-to-trough decline

-32.11%

-8.14%

-23.97%

Max Drawdown (1Y)

Largest decline over 1 year

-7.47%

Max Drawdown (3Y)

Largest decline over 3 years

-19.51%

Max Drawdown (5Y)

Largest decline over 5 years

-19.51%

Current Drawdown

Current decline from peak

0.00%

-0.97%

+0.97%

Average Drawdown

Average peak-to-trough decline

-5.81%

-1.94%

-3.87%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.53%

Volatility

FTXH vs. XLVI - Volatility Comparison


Loading charts...

Volatility by Period


FTXHXLVIDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.42%

Volatility (6M)

Calculated over the trailing 6-month period

12.04%

Volatility (1Y)

Calculated over the trailing 1-year period

17.18%

11.06%

+6.12%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.37%

11.06%

+5.31%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.42%

11.06%

+7.36%

FTXH vs. XLVI - Expense Ratio Comparison

FTXH has a 0.60% expense ratio, which is higher than XLVI's 0.35% expense ratio.


Dividends

FTXH vs. XLVI - Dividend Comparison

FTXH's dividend yield for the trailing twelve months is around 1.16%, less than XLVI's 11.17% yield.


PositionTTM2025202420232022202120202019201820172016
FTXH
First Trust Nasdaq Pharmaceuticals ETF
1.16%1.41%1.66%1.55%1.11%1.03%0.82%0.67%0.91%2.18%0.19%
XLVI
State Street Health Care Select Sector SPDR Premium Income ETF
11.17%5.73%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


FTXH and XLVI have a correlation of 0.83, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, XLVI is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.

XLVI is cheaper with a 0.35% expense ratio, compared with 0.60% for FTXH.

XLVI has the higher dividend yield at 11.17%, compared with 1.16% for FTXH.

FTXH is categorized as Health & Biotech Equities, while XLVI is Derivative Income. They also come from different issuers: First Trust and State Street. Their fees differ too: 0.60% for FTXH and 0.35% for XLVI.

Portfolio Optimizer

Find the right allocation for FTXH and XLVI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer